Connection

Bryan Heckman to Humans

This is a "connection" page, showing publications Bryan Heckman has written about Humans.
Connection Strength

0.480
  1. Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands. Nicotine Tob Res. 2019 05 21; 21(6):784-791.
    View in: PubMed
    Score: 0.025
  2. The impact of vaping and regulatory environment on cigarette demand: behavioral economic perspective across four countries. Addiction. 2019 10; 114 Suppl 1:123-133.
    View in: PubMed
    Score: 0.025
  3. Longer duration of smoking abstinence is associated with waning cessation fatigue. Behav Res Ther. 2019 04; 115:12-18.
    View in: PubMed
    Score: 0.024
  4. Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. J Consult Clin Psychol. 2018 Nov; 86(11):903-914.
    View in: PubMed
    Score: 0.024
  5. Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model. J Consult Clin Psychol. 2017 Apr; 85(4):381-396.
    View in: PubMed
    Score: 0.022
  6. Effectiveness of Switching Smoking-Cessation Medications Following Relapse. Am J Prev Med. 2017 Aug; 53(2):e63-e70.
    View in: PubMed
    Score: 0.021
  7. Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis. Addiction. 2015 May; 110(5):751-60.
    View in: PubMed
    Score: 0.019
  8. Influence of affective manipulations on cigarette craving: a meta-analysis. Addiction. 2013 Dec; 108(12):2068-78.
    View in: PubMed
    Score: 0.017
  9. The restorative effects of smoking upon self-control resources: a negative reinforcement pathway. J Abnorm Psychol. 2012 Feb; 121(1):244-9.
    View in: PubMed
    Score: 0.014
  10. Longitudinal Associations Between Pain and Use of Cigarettes and E-cigarettes in the Population Assessment of Tobacco and Health (PATH) Study. Nicotine Tob Res. 2023 02 09; 25(3):404-411.
    View in: PubMed
    Score: 0.008
  11. Illegal Experimental Tobacco Marketplace II: effects of vaping product bans - findings from the 2020 International Tobacco Control Project. Tob Control. 2022 11; 31(Suppl 3):s214-s222.
    View in: PubMed
    Score: 0.008
  12. The Predictive Utility of Valuing the Future for Smoking Cessation: Findings from the ITC 4 Country Surveys. Int J Environ Res Public Health. 2022 01 06; 19(2).
    View in: PubMed
    Score: 0.007
  13. The Illegal Experimental Tobacco Marketplace I: Effects of Vaping Product Bans. Nicotine Tob Res. 2021 08 29; 23(10):1744-1753.
    View in: PubMed
    Score: 0.007
  14. Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys. Tob Control. 2022 08; 31(e1):e66-e73.
    View in: PubMed
    Score: 0.007
  15. E-liquid purchase as a function of workplace restriction in the experimental tobacco marketplace. Exp Clin Psychopharmacol. 2022 Jun; 30(3):371-377.
    View in: PubMed
    Score: 0.007
  16. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes. Nicotine Tob Res. 2021 02 16; 23(3):438-446.
    View in: PubMed
    Score: 0.007
  17. Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse. Nicotine Tob Res. 2021 01 07; 23(1):186-194.
    View in: PubMed
    Score: 0.007
  18. The Experimental Tobacco Marketplace: Demand and Substitutability as a Function of Cigarette Taxes and e-Liquid Subsidies. Nicotine Tob Res. 2020 04 21; 22(5):782-790.
    View in: PubMed
    Score: 0.007
  19. The Impact of E-liquid Propylene Glycol and Vegetable Glycerin Ratio on Ratings of Subjective Effects, Reinforcement Value, and Use in Current Smokers. Nicotine Tob Res. 2020 04 21; 22(5):791-797.
    View in: PubMed
    Score: 0.007
  20. Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey. Tob Control. 2021 01; 30(1):94-97.
    View in: PubMed
    Score: 0.007
  21. Impact of E-cigarette Sampling on Cigarette Dependence and Reinforcement Value. Nicotine Tob Res. 2020 02 06; 22(2):297-301.
    View in: PubMed
    Score: 0.007
  22. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2020 01 27; 22(1):81-88.
    View in: PubMed
    Score: 0.007
  23. Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation. Psychol Addict Behav. 2020 Mar; 34(2):341-350.
    View in: PubMed
    Score: 0.006
  24. Smokers with pain are more likely to report use of e-cigarettes and other nicotine products. Exp Clin Psychopharmacol. 2020 Oct; 28(5):601-608.
    View in: PubMed
    Score: 0.006
  25. Rules about smoking and vaping in the home: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:107-114.
    View in: PubMed
    Score: 0.006
  26. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:15-23.
    View in: PubMed
    Score: 0.006
  27. Prices, use restrictions and electronic cigarette use-evidence from wave 1 (2016) US data of the ITC Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:115-122.
    View in: PubMed
    Score: 0.006
  28. A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. Addiction. 2019 10; 114 Suppl 1:24-34.
    View in: PubMed
    Score: 0.006
  29. Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:71-85.
    View in: PubMed
    Score: 0.006
  30. Cannabis use among a nationally representative cross-sectional sample of smokers and non-smokers in the Netherlands: results from the 2015 ITC Netherlands Gold Magic Survey. BMJ Open. 2019 03 03; 9(3):E024497.
    View in: PubMed
    Score: 0.006
  31. Where Do Vapers Buy Their Vaping Supplies? Findings from the International Tobacco Control (ITC) 4 Country Smoking and Vaping Survey. Int J Environ Res Public Health. 2019 01 26; 16(3).
    View in: PubMed
    Score: 0.006
  32. Methods of the ITC Four Country Smoking and Vaping Survey, wave 1 (2016). Addiction. 2019 10; 114 Suppl 1:6-14.
    View in: PubMed
    Score: 0.006
  33. Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
    View in: PubMed
    Score: 0.006
  34. State Tobacco Policies as Predictors of Evidence-Based Cessation Method Usage: Results From a Large, Nationally Representative Dataset. Nicotine Tob Res. 2018 09 25; 20(11):1336-1343.
    View in: PubMed
    Score: 0.006
  35. Delay discounting and e-cigarette use: An investigation in current, former, and never cigarette smokers. Drug Alcohol Depend. 2018 10 01; 191:165-173.
    View in: PubMed
    Score: 0.006
  36. Response to "Rapid Nicotine Ratio and Successful Quitting: Acceptable Explanation" by the Authors of "Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings from ITC Surveys in Five Countries". Nicotine Tob Res. 2018 06 07; 20(7):909.
    View in: PubMed
    Score: 0.006
  37. Experimental tobacco marketplace: substitutability of e-cigarette liquid for cigarettes as a function of nicotine strength. Tob Control. 2019 03; 28(2):206-211.
    View in: PubMed
    Score: 0.006
  38. One-Year Smoking Trajectories Among Established Adult Smokers With Low Baseline Motivation to Quit. Nicotine Tob Res. 2017 Dec 13; 20(1):50-57.
    View in: PubMed
    Score: 0.006
  39. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.006
  40. The differential impact of state tobacco control policies on cessation treatment utilization across established tobacco disparities groups. Prev Med. 2017 Dec; 105:319-325.
    View in: PubMed
    Score: 0.006
  41. Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries. Nicotine Tob Res. 2017 Sep 01; 19(9):1040-1047.
    View in: PubMed
    Score: 0.006
  42. Development and initial validation of a cessation fatigue scale. Drug Alcohol Depend. 2017 07 01; 176:102-108.
    View in: PubMed
    Score: 0.005
  43. A measure of perceived pain and tobacco smoking interrelations: pilot validation of the pain and smoking inventory. Cogn Behav Ther. 2017 06; 46(4):339-351.
    View in: PubMed
    Score: 0.005
  44. A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
    View in: PubMed
    Score: 0.005
  45. Acute analgesic effects of nicotine and tobacco in humans: a meta-analysis. Pain. 2016 07; 157(7):1373-1381.
    View in: PubMed
    Score: 0.005
  46. Health, Stigma, and the Burden of Smoking in College: A Thematic Analysis. Am J Health Behav. 2016 May; 40(3):381-8.
    View in: PubMed
    Score: 0.005
  47. Persistence and amplitude of cigarette demand in relation to quit intentions and attempts. Psychopharmacology (Berl). 2016 06; 233(12):2365-71.
    View in: PubMed
    Score: 0.005
  48. E-cigarette advertisements, and associations with the use of e-cigarettes and disapproval or quitting of smoking: Findings from the International Tobacco Control (ITC) Netherlands Survey. Int J Drug Policy. 2016 Mar; 29:73-9.
    View in: PubMed
    Score: 0.005
  49. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction. Psychol Addict Behav. 2015 Jun; 29(2):392-9.
    View in: PubMed
    Score: 0.005
  50. Smokers in pain report lower confidence and greater difficulty quitting. Nicotine Tob Res. 2014 Sep; 16(9):1272-6.
    View in: PubMed
    Score: 0.004
  51. Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes. Psychopharmacology (Berl). 2014 Jul; 231(13):2559-66.
    View in: PubMed
    Score: 0.004
  52. Decline in cue-provoked craving during cue exposure therapy for smoking cessation. Nicotine Tob Res. 2014 Mar; 16(3):306-15.
    View in: PubMed
    Score: 0.004
  53. Efficacy of an experiential, dissonance-based smoking intervention for college students delivered via the internet. J Consult Clin Psychol. 2013 Oct; 81(5):810-20.
    View in: PubMed
    Score: 0.004
  54. Variation in the a 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content. Pharmacogenomics J. 2014 Feb; 14(1):70-6.
    View in: PubMed
    Score: 0.004
  55. Outdoor smoking ban at a cancer center: attitudes and smoking behavior among employees and patients. J Public Health Manag Pract. 2012 Sep-Oct; 18(5):E24-31.
    View in: PubMed
    Score: 0.004
  56. Alcohol and group formation: a multimodal investigation of the effects of alcohol on emotion and social bonding. Psychol Sci. 2012 Aug 01; 23(8):869-78.
    View in: PubMed
    Score: 0.004
  57. Transient compensatory smoking in response to placebo cigarettes. Psychopharmacology (Berl). 2012 Sep; 223(1):47-54.
    View in: PubMed
    Score: 0.004
  58. Varenicline effects on craving, cue reactivity, and smoking reward. Psychopharmacology (Berl). 2011 Nov; 218(2):391-403.
    View in: PubMed
    Score: 0.004
  59. Effects of expectancies and coping on pain-induced motivation to smoke. J Abnorm Psychol. 2010 Aug; 119(3):524-33.
    View in: PubMed
    Score: 0.003
  60. A measure of smoking abstinence-related motivational engagement: development and initial validation. Nicotine Tob Res. 2010 Apr; 12(4):432-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.